The bioavailability and bioequivalence of a nasal spray depends on the droplet size.
But getting the droplet size just right involves multiple physical properties. From the physical properties of the formulation to how much energy is needed to drive atomization, and how that energy is stored and released.
What’s more, the droplet size of a nasal spray isn’t constant throughout the actuation. There are usually three distinct phases, not all of which deliver bioavailable droplets. So, investigating how the physical properties of the device and formulation affect the droplet size, and how droplet size changes during actuation, is key to fully understanding the bioavailability of nasal sprays.
Join Spraytec and analytical characterization expert John Ddungu, to learn:
- How to apply laser diffraction to reveal nasal spray atomization dynamics
- How this enables you to fully understand how formulation and device combine to produce droplets of just the right size
Speakers
- John Ddungu - Product Technical Specialist – Laser Diffraction, Malvern Panalytical
More information
Who should attend?
- Scientists interested in nasal spray development
- Pharmaceutical scientists working with novel spray formulations and process technologies
- Pharmaceutical scientists involved in the characterization of nasal sprays
What will you learn?
- Learn how to apply multiple physical properties impact nasal spray development
- Understand the analytical techniques that support in vitro bioequivalence assessment